Sorry, this entry is only available in Ukrainian.
Відродження після кризи: майбутні стратегії компаній у фармацевтичній галузі
Вас может заинтересовать:
WEB only
The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…
WEB only
On June 17-18, Kyiv hosted a remarkable popular science event dedicated to science for the victory and reconstruction of Ukraine. Our R&D scientists of YURiA-PHARM had the opportunity to share…
